Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,692.82
(
0.02%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BioBS2012

Send PM Follow Ignore
Followers 38
Posts 2971
Boards Moderated 0
Alias Born 10/07/2012

BioBS2012

Re: md1225 post# 198053

Friday, 11/28/2014 9:12:09 AM

Friday, November 28, 2014 9:12:09 AM

Post# of 347009

Very nice biopharm! This is great evidence to understand how the first look in could bring a trial halt!

If there is a halt at any point, it will be because of the difference in # of events between the Docetaxel arm and the BAVI+Docetaxel arm. They are not going to be doing any biomarker analysis in this trial so any biomarker talk is irrelevant to the Phase III NSCLC trial.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote